Management tracks: Nordic Nanovector, Molecular Partners

Cancer company Nordic Nanovector ASA (OSE:NANO) hired Eduardo Bravo as CEO, effective July 2. He was CEO at TiGenix N.V. (NASDAQ:TIG; Euronext:TIG).

Protein therapeutics company Molecular Partners AG (SIX:MOLN) said CSO Michael Stumpp has become COO. He is succeeded by Pamela Trail, who was VP of oncology strategy and program direction at Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)...